These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 37566006)

  • 21. Rescue of dendritic spine phenotype in Fmr1 KO mice with the mGluR5 antagonist AFQ056/Mavoglurant.
    Pop AS; Levenga J; de Esch CE; Buijsen RA; Nieuwenhuizen IM; Li T; Isaacs A; Gasparini F; Oostra BA; Willemsen R
    Psychopharmacology (Berl); 2014 Mar; 231(6):1227-35. PubMed ID: 23254376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early social enrichment rescues adult behavioral and brain abnormalities in a mouse model of fragile X syndrome.
    Oddi D; Subashi E; Middei S; Bellocchio L; Lemaire-Mayo V; Guzmán M; Crusio WE; D'Amato FR; Pietropaolo S
    Neuropsychopharmacology; 2015 Mar; 40(5):1113-22. PubMed ID: 25348604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased surface expression of the δ subunit of the GABA
    Zhang N; Peng Z; Tong X; Lindemeyer AK; Cetina Y; Huang CS; Olsen RW; Otis TS; Houser CR
    Exp Neurol; 2017 Nov; 297():168-178. PubMed ID: 28822839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The PDE10A Inhibitor TAK-063 Reverses Sound-Evoked EEG Abnormalities in a Mouse Model of Fragile X Syndrome.
    Jonak CR; Sandhu MS; Assad SA; Barbosa JA; Makhija M; Binder DK
    Neurotherapeutics; 2021 Apr; 18(2):1175-1187. PubMed ID: 33594533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gamma power abnormalities in a Fmr1-targeted transgenic rat model of fragile X syndrome.
    Kozono N; Okamura A; Honda S; Matsumoto M; Mihara T
    Sci Rep; 2020 Nov; 10(1):18799. PubMed ID: 33139785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exaggerated behavioral phenotypes in Fmr1/Fxr2 double knockout mice reveal a functional genetic interaction between Fragile X-related proteins.
    Spencer CM; Serysheva E; Yuva-Paylor LA; Oostra BA; Nelson DL; Paylor R
    Hum Mol Genet; 2006 Jun; 15(12):1984-94. PubMed ID: 16675531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence of reactive astrocytes but not peripheral immune system activation in a mouse model of Fragile X syndrome.
    Yuskaitis CJ; Beurel E; Jope RS
    Biochim Biophys Acta; 2010 Nov; 1802(11):1006-12. PubMed ID: 20600866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. STEP inhibition reverses behavioral, electrophysiologic, and synaptic abnormalities in Fmr1 KO mice.
    Chatterjee M; Kurup PK; Lundbye CJ; Hugger Toft AK; Kwon J; Benedict J; Kamceva M; Banke TG; Lombroso PJ
    Neuropharmacology; 2018 Jan; 128():43-53. PubMed ID: 28943283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endocannabinoid-mediated improvement on a test of aversive memory in a mouse model of fragile X syndrome.
    Qin M; Zeidler Z; Moulton K; Krych L; Xia Z; Smith CB
    Behav Brain Res; 2015 Sep; 291():164-171. PubMed ID: 25979787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reelin central fragment supplementation improves cognitive deficits in a mouse model of Fragile X Syndrome.
    Morrill NK; Joly-Amado A; Li Q; Prabhudeva S; Weeber EJ; Nash KR
    Exp Neurol; 2022 Nov; 357():114170. PubMed ID: 35863501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adult Fmr1 knockout mice present with deficiencies in hippocampal interleukin-6 and tumor necrosis factor-α expression.
    Hodges SL; Nolan SO; Taube JH; Lugo JN
    Neuroreport; 2017 Dec; 28(18):1246-1249. PubMed ID: 28915148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Restoration of FMRP expression in adult V1 neurons rescues visual deficits in a mouse model of fragile X syndrome.
    Yang C; Tian Y; Su F; Wang Y; Liu M; Wang H; Cui Y; Yuan P; Li X; Li A; Gong H; Luo Q; Zhu D; Cao P; Liu Y; Wang X; Luo MH; Xu F; Xiong W; Wang L; Li XY; Zhang C
    Protein Cell; 2022 Mar; 13(3):203-219. PubMed ID: 34714519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effects of melatonin against oxidative stress in Fmr1 knockout mice: a therapeutic research model for the fragile X syndrome.
    Romero-Zerbo Y; Decara J; el Bekay R; Sanchez-Salido L; Del Arco-Herrera I; de Fonseca FR; de Diego-Otero Y
    J Pineal Res; 2009 Mar; 46(2):224-34. PubMed ID: 19141086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early continuous inhibition of group 1 mGlu signaling partially rescues dendritic spine abnormalities in the Fmr1 knockout mouse model for fragile X syndrome.
    Su T; Fan HX; Jiang T; Sun WW; Den WY; Gao MM; Chen SQ; Zhao QH; Yi YH
    Psychopharmacology (Berl); 2011 May; 215(2):291-300. PubMed ID: 21181121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective Deletion of Astroglial FMRP Dysregulates Glutamate Transporter GLT1 and Contributes to Fragile X Syndrome Phenotypes In Vivo.
    Higashimori H; Schin CS; Chiang MS; Morel L; Shoneye TA; Nelson DL; Yang Y
    J Neurosci; 2016 Jul; 36(27):7079-94. PubMed ID: 27383586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BDNF in fragile X syndrome.
    Castrén ML; Castrén E
    Neuropharmacology; 2014 Jan; 76 Pt C():729-36. PubMed ID: 23727436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Audiogenic Seizures in the
    Gonzalez D; Tomasek M; Hays S; Sridhar V; Ammanuel S; Chang CW; Pawlowski K; Huber KM; Gibson JR
    J Neurosci; 2019 Dec; 39(49):9852-9863. PubMed ID: 31666356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive dysfunction and prefrontal synaptic abnormalities in a mouse model of fragile X syndrome.
    Krueger DD; Osterweil EK; Chen SP; Tye LD; Bear MF
    Proc Natl Acad Sci U S A; 2011 Feb; 108(6):2587-92. PubMed ID: 21262808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal in vivo developmental changes of metabolites in the hippocampus of Fmr1 knockout mice.
    Shi D; Xu S; Waddell J; Scafidi S; Roys S; Gullapalli RP; McKenna MC
    J Neurochem; 2012 Dec; 123(6):971-81. PubMed ID: 23046047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fmr1 knockout mice are impaired in a leverpress escape/avoidance task.
    Brennan FX; Albeck DS; Paylor R
    Genes Brain Behav; 2006 Aug; 5(6):467-71. PubMed ID: 16923151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.